Synchronization of molecular, metabolic, and cardiovascular circadian oscillations is
fundamental to human health. Sleep-disordered breathing, which disrupts such temporal …

Sleep apnea is evident in approximately 10% of adults in the general population, but in
certain cardiovascular diseases, and in particular those characterized by sodium and water …

Rationale: Randomized controlled trials have been unable to detect a cardiovascular benefit
of continuous positive airway pressure in unselected patients with obstructive sleep apnea …

Rationale: Obstructive sleep apnea is a risk factor for mortality, but its diagnostic metric—the
apnea–hypopnea index—is a poor risk predictor. The apnea–hypopnea index does not …

Background Excessive daytime sleepiness (EDS), a common symptom among patients with
sleep‐disordered breathing, is closely associated with the development of cardiovascular …

Obstructive and central sleep apnea are far more common in heart failure patients than in
the general population and their presence might contribute to the progression of heart failure …

Sleep‐disordered breathing—comprising obstructive sleep apnoea (OSA), central sleep
apnoea (CSA), or a combination of the two—is found in over half of heart failure (HF) …

Excessive daytime sleepiness (EDS) is a major symptom of obstructive sleep apnoea (OSA),
defined as the inability to stay awake during the day. Its clinical descriptors remain elusive …

Obstructive sleep apnea is more prevalent in patients with hypertension than in the general
population and many with obstructive sleep apnea also have hypertension. Obstructive …

Sleep apnea is frequently observed in patients with heart failure (HF). In general, sleep
apnea consists of two types: obstructive and central sleep apnea (OSA and CSA …